Comarit

Comarit uses and dosage

Comarit (Cabozantinib) is a prescription medicine used to treat metastatic medullary thyroid cancer (MTC). Cabozantinib medication blocks the action of a particular enzyme from working that helps to slow or stop the spread of cancer cells. Comarit manufactured by Genvio Pharma Ltd. in Bangladesh. Cabozantinib has to take orally once a day on an empty stomach (Do not eat for at least 2 hours before and at least 1 hour after taking dose).

Comarit side effects

The most common adverse reactions of Cabozantinib are: Dizziness, diarrhea, nausea, vomiting, mouth sores, constipation, stomach pain, tiredness, weakness, weight loss, decreased appetite, taste changes, hoarseness, and lightening of hair color.

Made by

Genvio Pharma

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.